$SLRX News Article - Salarius Completes Dose-Escal
Post# of 27
(Total Views: 273)
Posted On: 02/17/2021 3:45:48 PM
$SLRX News Article - Salarius Completes Dose-Escalation Stage of Phase 1/2 Clinical Trial in Relapsed and Refractory Ewing Sarcoma Patients, Initiates Expansion Stage in Ewing and Ewing-Related Sarcoma Patients https://marketwirenews.com/news-releases/sala...82157.html
(0)
(0)Salarius Pharmaceuticals, Inc. (SLRX) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼